C. Rogé

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 312 citations · Full text

Life Sciences, Immunology, Oncology +16

Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis

Vincent Esnault, Marie Audrain, C. Rogé et al. · Kidney International · 1993 · 218 citations

Life Sciences, Immunology, Molecular Genetics +13

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score

Laurent Bertoletti, Philippe Robin, Luis Jara‐Palomares et al. · Journal of Thrombosis and Haemostasis · 2017 · 33 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Quantification of CFTR splice variants in adults with disseminated bronchiectasis, using the TaqMan fluorogenic detection system

Joris Andrieux, M.P. Audrézet, I. Frachon et al. · Clinical Genetics · 2002 · 19 citations

Life Sciences, Genetics, Molecular Genetics +17